N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
about
Developments in the identification of glycan biomarkers for the detection of cancerSerum glycoprotein-derived N- and O-linked glycans as cancer biomarkersSimultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic methodDiscovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomicsPurification of derivatized oligosaccharides by solid phase extraction for glycomic analysisImproving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp.Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry.Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation statusIncreased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potentialSub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteinsAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens.Isolation and purification of glycoconjugates from complex biological sources by recycling high-performance liquid chromatographyThe Serum Immunoglobulin G Glycosylation Signature of Gastric CancerSialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.Applications of Multiple Reaction Monitoring to Clinical Glycomics.Proteomics in cancer biomarkers discovery: challenges and applications.Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MSN-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteinsStructural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis.Evaluation of riproximin binding properties reveals a novel mechanism for cellular targetingIncreased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis.Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins.Analytical glycobiology at high sensitivity: current approaches and directionsQuantitative glycomics strategiesDefining putative glycan cancer biomarkers by MS.B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1Glycosylation of plasma IgG in colorectal cancer prognosis.Recent trends in analytical and structural glycobiologyEnrichment strategies in glycomics-based lung cancer biomarker development.Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients.
P2860
Q27026715-B9916933-8AD1-4937-B840-82E2D57EC465Q28079101-3E79119B-96E0-45E8-A41E-04F3CD727133Q28468580-7CDAF726-BA65-48CF-9ECD-31294CB2DBDBQ28539618-7CB35E49-6F8B-4557-AA20-1B80CAC1FDFFQ28542008-DD6A4E88-FA70-4FC2-A694-5C10FA8DAB7BQ33456015-9D1E3063-1E9A-4A8E-80DE-E7A7B5BF6FBCQ33722717-FF5CB83C-1F12-4006-9556-09B1A7F00AA2Q33778489-DF9409C9-2453-42D7-9B84-33C10B19ECF6Q34092935-CFF0AE56-3BF4-42E3-BB2A-9580696A54CFQ34120306-2BFE7EF0-9A5B-4B8A-B938-AFABA6D8E411Q34157637-D040EEB7-0031-4204-8F66-423FE5FC7277Q34208137-5A9BC42D-0C74-4574-964D-0D0A4BF4CC37Q34320236-44D87DE0-F180-4231-8953-97E25FFE1BC4Q34489424-D2D7E993-B9A5-44F2-9395-94319CBA92CEQ34503577-AECB3421-395C-4D47-B188-A9D220E329B4Q34975642-5B2AE680-B403-4576-B74D-B6C67EE465C5Q34986720-21E9797B-3581-4689-B1DA-02E37EF673DCQ35000177-E0729D8B-1057-47F6-882C-F424AA9E7002Q35065968-E244AEA7-EB23-4EF5-8C03-0E281DD3637EQ35165824-3B8E9855-9617-448D-A61F-60A45EBDFDA6Q35213998-647EC5DC-ACBD-40FD-ADE8-E20188561BB8Q35447868-D4A819F9-2846-4CEE-9C86-CF0EFE2C265AQ35592114-AFE70D7B-2B12-4278-BD91-529CD4584700Q35874074-E7C69A13-EAE0-4B63-BC0B-D73D7B609354Q35886419-1176DF48-1421-441C-9A05-1DC478E76487Q36076879-56F2E65D-CB1B-480E-B6A2-BE1AE1CC0D2EQ36089872-8417D5FD-4187-4C99-8D0C-117386153E47Q36098576-60E0889D-6240-4239-B54D-B9438C11D7CAQ36332756-840D5AC9-A10D-4BF2-BEE1-C6ED890C0A47Q36339643-C2C9B4B3-1673-40DC-B134-D37EF8F01C18Q36342795-CB10204F-7C1C-40ED-A5A4-6F7207391BEAQ36362594-80654B75-7540-4A94-84D4-890EAD3D88A5Q36651493-8CDE5DCC-C8E6-4651-B56B-F08AA1BFCB89Q36742414-D3C17C7A-5A10-4C61-AF4B-04F2F4B84471Q36904030-64ADE535-93D9-46CA-A0F5-DBDF4E3C573DQ36973762-DF92CEE3-F70E-4E16-961B-3194F8FF7CAAQ37005714-3E9F0950-7AE1-4019-8679-40667D8FE33AQ37297209-1DAD2CF9-3BED-4F81-9223-84D9863A0701Q37446239-F33D1153-B218-4F11-9691-066C460F7480Q37480161-1E8884A2-409A-4197-902D-D88A943D0ED6
P2860
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
N-linked glycan structures and ...... ra of ovarian cancer patients.
@ast
N-linked glycan structures and ...... ra of ovarian cancer patients.
@en
type
label
N-linked glycan structures and ...... ra of ovarian cancer patients.
@ast
N-linked glycan structures and ...... ra of ovarian cancer patients.
@en
prefLabel
N-linked glycan structures and ...... ra of ovarian cancer patients.
@ast
N-linked glycan structures and ...... ra of ovarian cancer patients.
@en
P2093
P2860
P50
P356
P1476
N-linked glycan structures and ...... era of ovarian cancer patients
@en
P2093
Benjamin F Mann
Jacqueline A Vasseur
John A Goetz
Martin Svoboda
Milos V Novotny
Nancy Menning
William R Alley
P2860
P304
P356
10.1021/PR201070K
P577
2012-03-07T00:00:00Z